Reproductive Health

The Alpha Fetoprotein (AFP) Tumor Marker Test measures AFP levels in blood to help detect and monitor cancers such as liver cancer, testicular cancer, and certain ovarian tumors. Elevated AFP may also be seen with liver disease, cirrhosis, or hepatitis. Doctors order this test for patients at risk of or being treated for cancer. Results provide essential insight for diagnosis, monitoring treatment response, and tracking cancer recurrence or progression.

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

The Female Anti-Mullerian Hormone (AMH) Test measures AMH levels in blood to evaluate ovarian reserve and fertility potential. AMH reflects the number of eggs remaining and helps predict response to fertility treatments such as IVF. Doctors use this test to assess reproductive lifespan, investigate irregular cycles, or diagnose conditions like polycystic ovary syndrome (PCOS). Results provide key insight into fertility, ovarian health, and reproductive planning.

The Comprehensive Metabolic Panel (CMP) Test measures 21 markers to assess metabolic health, liver and kidney function, and electrolyte balance. It includes glucose, calcium, sodium, potassium, chloride, CO2, albumin, globulin, A/G ratio, total protein, bilirubin, ALP, AST, ALT, BUN, creatinine, BUN/creatinine ratio, and eGFR. The CMP helps detect diabetes, liver or kidney disease, and supports routine screening and chronic condition monitoring.

The DHEA Unconjugated Test measures levels of dehydroepiandrosterone, an adrenal hormone that serves as a precursor to testosterone and estrogen. Abnormal levels may indicate adrenal tumors, congenital adrenal hyperplasia, or hormone imbalance. Doctors order this test to evaluate infertility, irregular cycles, excess hair growth, or early puberty. Results provide insight into adrenal gland function, reproductive health, and endocrine disorders.

The DHEA Sulfate (DHEA-S) Test measures levels of DHEA-S, a hormone made by the adrenal glands, to evaluate adrenal function and hormone balance. It helps detect adrenal tumors, hyperplasia, or insufficiency and assess abnormal hair growth, infertility, or early/late puberty. Doctors also use it to investigate irregular menstrual cycles, monitor androgen disorders, and evaluate symptoms of hormone imbalance affecting reproductive and metabolic health.

The Estradiol (E2) Test measures levels of estradiol, the primary form of estrogen, to evaluate reproductive and hormonal health. It helps assess menstrual irregularities, fertility issues, menopause status, and estrogen-producing disorders. In men, it aids in diagnosing hormonal imbalances. Doctors use the estradiol test to monitor hormone therapy, ovarian function, and conditions affecting puberty, bone health, and overall endocrine balance.

The Estradiol Ultrasensitive Test measures very low levels of estradiol (E2), the primary form of estrogen, to evaluate reproductive and endocrine health. It is especially useful for men, children, postmenopausal women, and patients on hormone therapy. Doctors use this test to assess fertility issues, menstrual irregularities, delayed or early puberty, and monitor treatment for hormone-sensitive cancers or endocrine disorders.

The Estriol (E3) Test checks blood levels of estriol, an estrogen hormone important in pregnancy. It is commonly included in the second-trimester triple or quad screen to detect chromosomal disorders such as Down syndrome and assess placental function. Estriol testing helps monitor fetal growth and maternal hormone health. Low or abnormal levels may signal pregnancy complications, guiding further testing and prenatal care decisions.

The Estrogen Total Test measures all forms of estrogen in blood, including estradiol, estrone, and estriol, to assess reproductive and hormonal health. Abnormal levels may indicate menstrual irregularities, menopause status, infertility, or hormone-related disorders. Doctors order this test to evaluate fertility, monitor hormone therapy, and investigate symptoms such as hot flashes, irregular cycles, or abnormal bleeding. It provides key insight into endocrine and reproductive function.

The Fractionated Estrogens Test measures individual estrogen hormones, including estrone (E1), estradiol (E2), and estriol (E3), to evaluate reproductive and endocrine health. Abnormal levels may indicate menopause, infertility, ovarian disorders, or pregnancy complications. Doctors use this test to assess hormonal balance, investigate irregular cycles, and guide treatment decisions. It is also valuable for monitoring hormone therapy and evaluating estrogen-related conditions.

The Estrone (E1) Test measures estrone, one of the three main estrogen hormones, to assess reproductive and hormonal health. It helps evaluate ovarian function, menstrual irregularities, menopause status, and estrogen-related disorders. In men, estrone testing may detect hormonal imbalances or excess estrogen. Doctors use this test to monitor hormone therapy, fertility treatments, and conditions affecting bone health, metabolism, and overall endocrine balance.

The Ferritin Test measures ferritin, a protein that stores iron in the body, to evaluate iron levels and detect deficiency or overload. It helps diagnose anemia, iron deficiency, hemochromatosis, and chronic disease-related inflammation. Doctors often order the ferritin test to investigate fatigue, weakness, or unexplained symptoms. It is also used to monitor iron supplementation, treatment effectiveness, and overall iron metabolism health.

The Ferritin, Iron and Total Iron Binding Capacity Panel measures ferritin, iron, TIBC, and % iron saturation to assess how well your body stores and transports iron. This panel helps detect iron deficiency, anemia, or iron overload, providing insight into energy levels, oxygen transport, and overall metabolic health.

The Follicle-Stimulating Hormone (FSH) Test measures FSH levels to evaluate reproductive and endocrine health in both men and women. In women, it helps assess infertility, irregular periods, menopause, or ovarian function. In men, it is used to check sperm production and testicular function. Abnormal results may indicate PCOS, pituitary disorders, or hormonal imbalance. Doctors order this test to guide fertility treatment, hormone therapy, and overall reproductive care.

The FSH and LH Test measures follicle-stimulating hormone (FSH) and luteinizing hormone (LH) to evaluate reproductive and endocrine health in both men and women. In women, it helps assess menstrual irregularities, infertility, menopause, or polycystic ovary syndrome (PCOS). In men, it aids in diagnosing low testosterone, infertility, or testicular dysfunction. Doctors also use this test to investigate puberty disorders, hormone imbalance, and pituitary function.

The Iron Total and Total Iron Binding Capacity (TIBC) Test measures iron levels in blood along with the blood’s ability to transport iron. It helps diagnose iron deficiency anemia, iron overload (hemochromatosis), and monitor nutritional or chronic health conditions. Low iron or high TIBC may indicate anemia, while high iron or low TIBC can suggest overload. Doctors use this test to evaluate fatigue, weakness, or other symptoms linked to iron and metabolic health.

The LH Test measures luteinizing hormone levels in blood to assess fertility, reproductive health, and endocrine function. Abnormal LH may indicate infertility, menstrual irregularities, menopause, or pituitary disorders in women, and low testosterone or testicular dysfunction in men. Doctors use this test to evaluate ovulation, investigate infertility, monitor puberty disorders, or guide hormone therapy. It provides key insight into reproductive and hormonal balance.

The Maternal AFP Test evaluates alpha-fetoprotein levels during pregnancy to assess fetal development and identify possible abnormalities. Variations in AFP may signal neural tube defects, abdominal wall issues, or genetic conditions such as trisomy 21. As part of prenatal screening, this test provides insight into maternal health and supports early evaluation of fetal growth and pregnancy outcomes.

The Post-Vasectomy Spermatozoa Qualitative Test checks for the presence of sperm in semen after a vasectomy to confirm the success of the procedure. This post-vasectomy semen analysis is essential to ensure sterility, verify the effectiveness of surgery, and reduce the risk of unintended pregnancy. Doctors use this sperm test to confirm no live sperm remain, providing patients confidence in their vasectomy results and long-term reproductive planning.

The Progesterone Test measures progesterone levels in blood to evaluate ovulation, fertility, and menstrual health. It helps confirm whether ovulation has occurred, assess causes of infertility, and monitor hormone therapy or high-risk pregnancies. Doctors also use it to investigate abnormal bleeding, detect ovarian or adrenal disorders, and evaluate miscarriage risk. This test provides key insight into reproductive, hormonal, and overall endocrine health.

The Progesterone Ultrasensitive Test measures very low progesterone levels in blood with high accuracy to evaluate reproductive and endocrine health. Doctors use it to assess menstrual cycle function, confirm ovulation, investigate infertility, and monitor hormone therapy. It is also useful in pregnancy evaluation and detecting hormonal disorders. Results provide precise insight into progesterone balance, fertility, and overall reproductive health.